Background: The introduction of adjuvant therapies for patients with resected cutaneous melanoma (CM) has increased the need for sensitive biomarkers for risk stratification and disease monitoring. Th…

Read more about 'Circulating tumor DNA assessment shows promising results in predicting and reflecting disease status during adjuvant therapy'...

Posted in Research; Posted 10 months ago 1 Minute(s) to read